Evidence map›Paper›PMID 34452099›Full record

ArticlePharmaceutics2021

Development of an Immunochromatographic Strip Using Conjugated Gold Nanoparticles for the Rapid Detection of

Noha M Elhosseiny, Tamer M Samir, Aliaa A Ali, Amani A El-Kholy, Ahmed S Attia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Noha M ElhosseinyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0002-8980-0316
Tamer M SamirDepartment of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Cairo 12573, Egypt.ORCID 0000-0002-1504-7843
Aliaa A AliDepartment of Pediatrics, Faculty of Medicine, Cairo University, Cairo 11562, Egypt.
Amani A El-KholyDepartment of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt.
Ahmed S AttiaDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0003-0491-1007
Cairo University · EGMisr University for Science and Technology · EG

Funding

Science and Technology Development Fund 13886
6 · The paper itself

Abstract

Neonatal sepsis is a leading cause of death among newborns and infants, especially in the developing world. The problem is compounded by the delays in pinpointing the causative agent of the infection. This is reflected in increasing mortality associated with these cases and the spread of multi-drug-resistant bacteria. In this work, we deployed bioinformatics and proteomics analyses to determine a promising target that could be used for the identification of a major neonatal sepsis causative agent,

Indexed as

diagnosisgold nanoparticlesimmunochromatographic stripK. pneumoniaeneonatal sepsisrapid

Identifiers

PMID34452099
PMCPMC8401635
OpenAlexW3185631399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.